BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 30320443)

  • 1. Taxane-based chemohormonal therapy for metastatic hormone-sensitive prostate cancer.
    Sathianathen NJ; Philippou YA; Kuntz GM; Konety BR; Gupta S; Lamb AD; Dahm P
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD012816. PubMed ID: 30320443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abiraterone acetate in combination with androgen deprivation therapy compared to androgen deprivation therapy only for metastatic hormone-sensitive prostate cancer.
    Sathianathen NJ; Oestreich MC; Brown SJ; Gupta S; Konety BR; Dahm P; Kunath F
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013245. PubMed ID: 33314020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early versus deferred standard androgen suppression therapy for advanced hormone-sensitive prostate cancer.
    Kunath F; Jensen K; Pinart M; Kahlmeyer A; Schmidt S; Price CL; Lieb V; Dahm P
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD003506. PubMed ID: 31194882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pembrolizumab monotherapy versus chemotherapy for treatment of advanced urothelial carcinoma with disease progression during or following platinum-containing chemotherapy. A Cochrane Rapid Review.
    Narayan V; Kahlmeyer A; Dahm P; Skoetz N; Risk MC; Bongiorno C; Patel N; Hwang EC; Jung JH; Gartlehner G; Kunath F
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD012838. PubMed ID: 30036453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Degarelix for treating advanced hormone-sensitive prostate cancer.
    Zengerling F; Jakob JJ; Schmidt S; Meerpohl JJ; Blümle A; Schmucker C; Mayer B; Kunath F
    Cochrane Database Syst Rev; 2021 Aug; 8(8):CD012548. PubMed ID: 34350976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy for advanced or metastatic urothelial carcinoma.
    Maisch P; Hwang EC; Kim K; Narayan VM; Bakker C; Kunath F; Dahm P
    Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013774. PubMed ID: 37811690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radical prostatectomy versus deferred treatment for localised prostate cancer.
    Vernooij RW; Lancee M; Cleves A; Dahm P; Bangma CH; Aben KK
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD006590. PubMed ID: 32495338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonates or RANK-ligand-inhibitors for men with prostate cancer and bone metastases: a network meta-analysis.
    Jakob T; Tesfamariam YM; Macherey S; Kuhr K; Adams A; Monsef I; Heidenreich A; Skoetz N
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013020. PubMed ID: 33270906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taxane monotherapy regimens for the treatment of recurrent epithelial ovarian cancer.
    Patel A; Kalachand R; Busschots S; Doherty B; Kapros E; Lawlor D; Hall N; Stordal BK
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD008766. PubMed ID: 35866378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-steroidal antiandrogen monotherapy compared with luteinising hormone-releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer.
    Kunath F; Grobe HR; Rücker G; Motschall E; Antes G; Dahm P; Wullich B; Meerpohl JJ
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD009266. PubMed ID: 24979481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
    Hwang EC; Jung JH; Borofsky M; Kim MH; Dahm P
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD013143. PubMed ID: 30759311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circumcision devices versus standard surgical techniques in adolescent and adult male circumcisions.
    Hohlfeld A; Ebrahim S; Shaik MZ; Kredo T
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD012250. PubMed ID: 33786810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Robotic versus open radical cystectomy for bladder cancer in adults.
    Rai BP; Bondad J; Vasdev N; Adshead J; Lane T; Ahmed K; Khan MS; Dasgupta P; Guru K; Chlosta PL; Aboumarzouk OM
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD011903. PubMed ID: 31016718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transurethral microwave thermotherapy for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
    Franco JV; Garegnani L; Escobar Liquitay CM; Borofsky M; Dahm P
    Cochrane Database Syst Rev; 2021 Jun; 6(6):CD004135. PubMed ID: 34180047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended versus standard lymph node dissection for urothelial carcinoma of the bladder in patients undergoing radical cystectomy.
    Hwang EC; Sathianathen NJ; Imamura M; Kuntz GM; Risk MC; Dahm P
    Cochrane Database Syst Rev; 2019 May; 5(5):CD013336. PubMed ID: 31111956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-escalated radiotherapy for clinically localized and locally advanced prostate cancer.
    Kim S; Kong JH; Lee Y; Lee JY; Kang TW; Kong TH; Kim MH; You SH
    Cochrane Database Syst Rev; 2023 Mar; 3(3):CD012817. PubMed ID: 36884035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retzius-sparing versus standard robotic-assisted laparoscopic prostatectomy for the treatment of clinically localized prostate cancer.
    Rosenberg JE; Jung JH; Edgerton Z; Lee H; Lee S; Bakker CJ; Dahm P
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013641. PubMed ID: 32813279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Robot-assisted vs open radical cystectomy for bladder cancer in adults.
    Rai BP; Bondad J; Vasdev N; Adshead J; Lane T; Ahmed K; Khan MS; Dasgupta P; Guru K; Chlosta PL; Aboumarzouk OM
    BJU Int; 2020 Jun; 125(6):765-779. PubMed ID: 31309688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticholinergics combined with alpha-blockers for treating lower urinary tract symptoms related to benign prostatic obstruction.
    Pang R; Zhou XY; Wang X; Wang B; Yin XL; Bo H; Jung JH
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD012336. PubMed ID: 33567116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.